sur BioVersys AG
BioVersys to Present at Stifel 2025 Annual Healthcare Conference
BioVersys AG, a biopharmaceutical company based in Basel, Switzerland, will present its latest clinical and preclinical developments at the Stifel 2025 Annual Healthcare Conference. This event is scheduled to take place from November 11-13, 2025, at the Lotte New York Palace Hotel in New York City.
The presentation will occur on November 12, 2025, at 4:40 PM Eastern Time. The company's CEO, Marc Gitzinger, and CFO, Hernan Levett, will highlight BioVersys's innovations in combating multi-drug resistant bacterial infections. Attendees can view the presentation via webcast with prior registration.
Additionally, the BioVersys management team will conduct one-on-one meetings during the conference. Interested institutional investors are encouraged to schedule these meetings through their conference representatives.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BioVersys AG